Bybit to Launch Indonesia Platform Following Majority Acquisition of NOBI
DUBAI, UAE, July 16, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has launched a locally operated... Read more.
Bell Media Expands Investment in Premium Original Drama with First-Look Development Deal with Jeff Frost’s Bristol Circle Entertainment
– This pact marks a first-time partnership between Bell Media and PLURIBUS producer Bristol Circle Entertainment –– The partnership focuses on developing original... Read more.
Blue Energy Receives Strategic Investment from Constellation to Accelerate Commercialization of Novel Shipyard Manufacturing and Project Financing Model for New Nuclear
CHEVY CHASE, Md., July 16, 2026 /PRNewswire/ — Blue Energy, a developer of financeable, prefabricated nuclear power plants, today announced a strategic equity... Read more.
John Snow Labs Ranked Highest in the MarketsandMarkets™ 360Quadrant for NLP in Healthcare and Life Sciences
DELRAY BEACH, Fla., July 16, 2026 /PRNewswire/ — John Snow Labs, the industry leader in medical language models, has been ranked highest, at the top of the... Read more.
LifeLens Technologies, Inc. Announces 510(k) Clearance of Expanded Vital Sign Monitoring Indications for the LifeLens Physiological Monitor
IVYLAND, Pa., July 16, 2026 /PRNewswire/ — LifeLens Technologies, Inc. (LifeLens), today announced the latest FDA 510(k) clearance for the company’s... Read more.
Checkers & Rally’s Doubles Down on Value with Unbeatable Meal Deal and Bold Menu Innovations
Meal deal, loaded wrap, indulgent burger and cheesy snack deliver more flavor and value – now available nationwide TAMPA, Fla., July 16, 2026 /PRNewswire/ —... Read more.
ScaleFlux CEO to Deliver FMS 2026 Keynote with NVIDIA on Memory Solutions to Scale AI Data Pipeline
ScaleFlux experts will lead seven presentations, including a keynote with NVIDIA, covering AI data infrastructure, CXL memory, SSD architecture, storage security,... Read more.
Complement 3 Glomerulopathy Market Set for Transformation: 4 Emerging Therapies Leading the Next Growth Phase | DelveInsight
Emerging therapies targeting novel mechanisms such as dual complement inhibitors (C5 and Factor H (KP104), MASP-3 inhibitors (Zaltenibart), RNA interference (RNAi)... Read more.
CHEER TOGETHER IN REAL TIME WITH SPECTRUM TV CONTROL PRO FROM SPECTRUM BUSINESS
New Solution for Bars, Restaurants and Other Commercial Venues Keeps TVs in Sync with Centralized Controls Key Takeaways: With Spectrum TV Control Pro, businesses... Read more.
Oligonucleotide Synthesis Market worth $32.72 billion by 2031 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., July 16, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Oligonucleotide Synthesis Market is projected to reach USD 32.72 billion... Read more.